{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:10:38Z","timestamp":1782738638906,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.nucmedbio.2019.12.002","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T04:54:16Z","timestamp":1575867256000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation"],"prefix":"10.1016","volume":"82-83","author":[{"given":"Jeroen","family":"Verhoeven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Baguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Piron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Pauwelyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Bouckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Descamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robrecht","family":"Raedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vanhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Goethals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0005","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.clineuro.2010.06.005","article-title":"Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18 F-FDG PET, 11 C- methionine PET and perfusion MRI","volume":"112","author":"Kim","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0010","doi-asserted-by":"crossref","DOI":"10.1259\/bjr\/18061999","article-title":"Diagnosis and treatment in neuro-oncology: an oncological perspective","volume":"84","author":"Rees","year":"2011","journal-title":"Br J Radiol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1215\/15228517-2008-008","article-title":"Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology","volume":"10","author":"Brandes","year":"2008","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nucmedbio.2014.07.006","article-title":"F18-fluoromethylcholine (FCho), F18-fluoroethyltyrosine (FET) and F18-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma (HGG) and radiation necrosis (RN): a {mu}PET study","volume":"42","author":"Bolcaen","year":"2015","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fonc.2018.00395","article-title":"Diagnosis and management of radiation necrosis in patients with brain metastases","volume":"8","author":"Vellayappan","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11060-010-0139-3","article-title":"Treatment induced necrosis versus recurrent\/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging","volume":"100","author":"Jain","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00259-004-1564-3","article-title":"Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value","volume":"32","author":"Van Laere","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00259-016-3487-1","article-title":"18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-methionine PET","volume":"44","author":"Watabe","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1148\/radiographics.12.2.1561416","article-title":"Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET","volume":"12","author":"Kim","year":"1992","journal-title":"Radiographics"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000099813","article-title":"Positron emission tomography using 18F-fluorodeoxyglucose in patients with stereotactically irradiated brain metastases","volume":"66","author":"Ericson","year":"1995","journal-title":"Stereotctic Funct Neurosurg"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.410290403","article-title":"Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography","volume":"29","author":"Glantz","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0060","first-page":"1861","article-title":"PET in differentiation of recurrent brain tumor from radiation injury","volume":"41","author":"Langleben","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0065","first-page":"407","article-title":"Differentiating recurrent tumor from radiation necrosis: time for re- evaluation of positron emission tomography?","volume":"19","author":"Ricci","year":"1998","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/ijc.1016","article-title":"The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery","volume":"96","author":"Chao","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cpet.2014.09.005","article-title":"18F-fluorodeoxyglucose PET\/computed tomography for primary brain tumors","volume":"10","author":"Segtnan","year":"2015","journal-title":"PET Clin"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymeth.2017.05.019","article-title":"Imaging of amino acid transport in brain tumours: positron emission tomography with O-(2-[18F]fluoroethyl)-L-tyrosine (FET)","volume":"130","author":"Langen","year":"2017","journal-title":"Methods"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.113.121418","article-title":"18F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment","volume":"55","author":"Lizarraga","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0090","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/neuonc\/not166","article-title":"Comparison of visual and semiquantitative analysis of 18F-FDOPA- PET\/CT for recurrence detection in glioblastoma patients","volume":"16","author":"Herrmann","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0095","series-title":"Accuracy of 18F-FDOPA positron emission tomography and 18F-FET positron emission tomography for differentiating radiation necrosis from brain tumor recurrence","volume":"114","author":"Yu","year":"2018"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0100","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2967\/jnumed.112.103325","article-title":"Role of O-(2-18F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis","volume":"53","author":"Galldiks","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0105","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2967\/jnumed.111.098590","article-title":"Assessment of treatment response in patients with glioblastoma using O-(2-18F-Fluoroethyl)-L-tyrosine PET in comparison to MRI","volume":"53","author":"Galldiks","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00259-005-0053-7","article-title":"Serial O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma","volume":"33","author":"P\u00f6pperl","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.nucmedbio.2006.01.002","article-title":"O-(2-[18F]fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications","volume":"33","author":"Langen","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077476","article-title":"Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET","volume":"8","author":"Ikotun","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0125","first-page":"1591","article-title":"SPECT and PET amino acid tracer influx via system L (h 4F2 hc - h LAT1) and its transstimulation","volume":"45","author":"Lahoutte","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0130","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.2967\/jnumed.107.046615","article-title":"Differential uptake of O-(2-18F-Fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscesses","volume":"48","author":"Salber","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0135","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2967\/jnumed.109.071423","article-title":"Comparison of O-(2-18F-fluoroethyl)-L-tyrosine and L-3H-methionine uptake in cerebral hematomas","volume":"51","author":"Salber","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0140","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.nucmedbio.2006.09.004","article-title":"Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia","volume":"33","author":"Salber","year":"2006","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0145","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.nucmedbio.2013.05.001","article-title":"Uptake of O-(2-[18F]fluoroethyl)-L-tyrosine in reactive astrocytosis in the vicinity of cerebral gliomas","volume":"40","author":"Piroth","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-40013-x","article-title":"New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma","volume":"9","author":"Verhoeven","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0155","article-title":"(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study","author":"Bolcaen","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-019-1290-4","article-title":"Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model","volume":"14","author":"Verhoeven","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0165","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s11307-017-1071-0","article-title":"In vivo DCE-MRI for the discrimination between glioblastoma and radiation necrosis in rats","volume":"19","author":"Bolcaen","year":"2017","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2009.06.007","article-title":"A novel murine model for localized radiation necrosis and its characterization using advanced magnetic resonance imaging","volume":"75","author":"Jost","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0175","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.2268","article-title":"Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides","volume":"17","author":"Zhou","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0180","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaa034","article-title":"Prediction of radiation necrosis in a rodent model using magnetic resonance imaging apparent transverse relaxation (R2\u2217)","volume":"63","author":"Belliveau","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/6828396","article-title":"Tumor recurrence: imaging challenges for the evaluation of treated gliomas","volume":"2018","author":"Zikou","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0190","first-page":"1293","article-title":"The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma","volume":"17","author":"Galldiks","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0195","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00259-015-3274-4","article-title":"Reproducibility of O-(2-18F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas","volume":"43","author":"Stegmayr","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11060-015-1883-1","article-title":"The use of 18F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma","volume":"125","author":"Dankbaar","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-009-9897-1","article-title":"Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities","volume":"95","author":"Alexiou","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.semnuclmed.2012.02.003","article-title":"Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity","volume":"42","author":"Schillaci","year":"2012","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0215","first-page":"1653","article-title":"18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter","volume":"45","author":"Spence","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0220","article-title":"Delayed fluorodeoxyglucose positron emission tomography imaging in the differentiation of tumor recurrence and radiation necrosis in pediatric central nervous system tumors: case report and review of the literature","volume":"10","author":"Wadhwa","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0225","first-page":"1301","article-title":"High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue","volume":"36","author":"Yamada","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0230","first-page":"1551","article-title":"FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models","volume":"42","author":"Mochizuki","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0235","first-page":"532","article-title":"In vivo characterization of 123\/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT","volume":"46","author":"Kersemans","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0240","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.nucmedbio.2009.03.009","article-title":"Comparison of 18F-FDG,18F-FET and18F-FLT for differentiation between tumor and inflammation in rats","volume":"36","author":"Lee","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0245","doi-asserted-by":"crossref","first-page":"259ra146","DOI":"10.1126\/scitranslmed.3009815","article-title":"Imaging enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography","volume":"6","author":"Weinstein","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-52270-x","article-title":"18F-FIMP: a LAT1-specific PET probe for discrimination between tumor tissue and inflammation","volume":"9","author":"Nozaki","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-017-0763-6","article-title":"Relationship between the uptake of18F-borono-L-phenylalanine and L-[methyl-11C] methionine in head and neck tumors and normal organs","volume":"12","author":"Watanabe","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.nucmedbio.2019.12.002_bb0260","first-page":"1","article-title":"Radiation necrosis \u2013 a growing problem in a case of brain metastases following whole brain radiotherapy and stereotactic radiosurgery","volume":"10","author":"Song","year":"2018","journal-title":"Cureus"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805119305049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805119305049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:28:36Z","timestamp":1760848116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805119305049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":52,"alternative-id":["S0969805119305049"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2019.12.002","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-[18F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2019.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}